Product Specification| Host | Human | | Antigen | PD-L1 | | Synonyms | Programmed cell death 1 ligand 1, PDCD1 ligand 1, Programmed death ligand 1, hPD-L1, B7 homolog 1, B7-H1, CD274, B7H1, PDCD1L1, PDCD1LG1 | | Accession | Q9NZQ7 | | Clone Number | S-SC0101 | | Antibody Type | Recombinant mAb | | Isotype | IgG1,k | | Application | Blocking of PD-1/PD-L1 signaling Functional assays | | Purification | Protein A | | Concentration | 2 mg/ml | | Endotoxin | <1EU/mg | | Conjugation | Unconjugated | | Physical Appearance | Liquid | | Storage Buffer | PBS pH7.4, containing no preservative | | Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution| application | dilution | species | | ELISA | 1.221-5000 ng/ml | |
BackgroundDurvalumab is an immunotherapy for cancer. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 (CD279). bio-equip.cn AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
|
中文
